Production (Stage)
Black Diamond Therapeutics, Inc.
BDTX
$2.25
$0.2613.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 453.72% | -2.75% | 21.86% | -9.24% | 6.10% |
| Total Depreciation and Amortization | 2.35% | -1.16% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.88% | -0.66% | -65.74% | 223.39% | 4.72% |
| Change in Net Operating Assets | -544.61% | -132.96% | 1,041.01% | 104.75% | -216.41% |
| Cash from Operations | 454.77% | -32.96% | 23.11% | 30.53% | -51.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 62.50% | -83.33% | 26.32% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.26% | 1,194.22% | 205.56% | 105.11% | -212.12% |
| Cash from Investing | -69.22% | 1,166.26% | 196.35% | 105.39% | -212.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.00% | -- | -- | 417.63% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.00% | 215.48% | -101.18% | 417.63% | 9,078.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 376.66% | 238.62% | -226.92% | 124.00% | -1,657.16% |